Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival

  • G. Ralph Corey, Marin H. Kollef, Andrew F. Shorr, Ethan Rubinstein, Martin E. Stryjewski, Alan Hopkins, Steven L. Barriere
  • Antimicrobial Agents and Chemotherapy, January 2014, ASM Journals
  • DOI: 10.1128/aac.02330-13

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1128/aac.02330-13

The following have contributed to this page: Dr Steven Barriere